Sector Update: Healthcare

By
A A A

Healthcare shares are generally higher in pre-market trade.

Ariad Pharmaceuticals ( ARIA ) is up more than about 3% pre-market, easing off stronger gains, gaining for a fourth session, amid speculation it may be a takeover target for a larger drug maker. ARIA closed up 19% Friday.

And, BioCryst Pharmaceuticals, Inc. ( BCRX ) is down about 10% pre-market after it was downgraded by Wells Fargo to a Market Perform rating from Outperform. The firm set the stock's price range at $9-$10 a share.

Finally, blood management solutions provider Haemonetics Corporation ( HAE ) is down 3% after it said its adjusted EPS for Q3 2014 was up 5% year-over-year to $0.61, a penny better than the Capital IQ consensus.

Net revenues were down 2% from last year to $242.1 million, versus the $244 million analyst estimate.

For fiscal 2014, the company continues to expect adjusted EPS of $2.30 to $2.40, which compares to the $2.32 street view. Overall fiscal 2014 organic revenue is still expected to grow 2%-4% in constant currency and 0%-2% on a reported basis.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ARIA , BCRX , HAE

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

68,973,020
  • $61.72 ▼ 3.46%
36,346,016
  • $15.44 ▼ 1.03%
28,708,525
  • $65.06 ▲ 0.14%
27,938,926
  • $4.32 ▲ 2.13%
25,951,456
  • $3.385 ▲ 1.04%
21,685,401
  • $94.79 ▼ 0.63%
20,800,956
  • $32.80 ▲ 0.43%
20,374,371
  • $94.72 ▼ 0.25%
As of 7/10/2014, 12:53 PM